Identification and Characterization of New Molecular Partners for the Protein Arginine Methyltransferase 6 (PRMT6)

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Lo Sardo, Alessandra ^a,b   Altamura, Sandro ^a,c   Pegoraro, Silvia ^a   Maurizio, Elisa ^a   Sgarra, Riccardo ^a   Manfioletti, Guidalberto ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CYCLIN DEPENDENT KINASE 9; HEAT SHOCK PROTEIN 27; HIGH MOBILITY GROUP A1A PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; METHYLTRANSFERASE; NUCLEOSIDE DIPHOSPHATE KINASE A; PEROXIREDOXIN 4; PROTEIN ARGININE METHYLTRANSFERASE 6; PROTEIN CDK5RAP3; PROTEIN EBP1; PROTEIN FTL; PROTEIN GRSF 1; PROTEIN HINT1; PROTEIN HNRNP Q; PROTEIN HPRT1; PROTEIN HYPK; PROTEIN MED28; PROTEIN MRPL38; PROTEIN MTF2; PROTEIN NOB1; PROTEIN POMP; PROTEIN PRPF39; PROTEIN PSMB4; PROTEIN PSMD11; PROTEIN PSME1; PROTEIN SAAL1; PROTEIN SNRNPB; PROTEIN UTP6; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; IN VITRO STUDY; IN VIVO STUDY; PROTEIN ASSEMBLY; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PROTEIN INTERACTION;

CHROMATOGRAPHY, AFFINITY; HMGA1A PROTEIN; HUMANS; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEIN-ARGININE N-METHYLTRANSFERASES; REPRODUCIBILITY OF RESULTS; SUBSTRATE SPECIFICITY; TWO-HYBRID SYSTEM TECHNIQUES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84872250137     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053750     Document Type: Article

References (42)

1. Bedford MT, Clarke SG, (2009) Protein arginine methylation in mammals: who, what, and why. Mol Cell 33: 1-13.
2. Bedford MT, (2007) Arginine methylation at a glance. J Cell Sci 120: 4243-4246.
3. Vallance P, (2001) Importance of asymmetrical dimethylarginine in cardiovascular risk. Lancet 358: 2096-2097.
4. Krause CD, Yang ZH, Kim YS, Lee JH, Cook JR, et al. (2007) Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential. Pharmacol Ther 113: 50-87.
5. Frankel A, Yadav N, Lee J, Branscombe TL, Clarke S, et al. (2002) The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity. J Biol Chem 277: 3537-3543.
6. Guccione E, Bassi C, Casadio F, Martinato F, Cesaroni M, et al. (2007) Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature 449: 933-937.
7. Hyllus D, Stein C, Schnabel K, Schiltz E, Imhof A, et al. (2007) PRMT6-mediated methylation of R2 in histone H3 antagonizes H3 K4 trimethylation. Genes Dev 21: 3369-3380.
8. Iberg AN, Espejo A, Cheng D, Kim D, Michaud-Levesque J, et al. (2008) Arginine methylation of the histone H3 tail impedes effector binding. J Biol Chem 283: 3006-3010.
9. Waldmann T, Izzo A, Kamieniarz K, Richter F, Vogler C, et al. (2011) Methylation of H2AR29 is a novel repressive PRMT6 target. Epigenetics Chromatin 4: 11.
10. Miranda TB, Webb KJ, Edberg DD, Reeves R, Clarke S, (2005) Protein arginine methyltransferase 6 specifically methylates the nonhistone chromatin protein HMGA1a. Biochem Biophys Res Commun 336: 831-835.
11. Sgarra R, Lee J, Tessari MA, Altamura S, Spolaore B, et al. (2006) The AT-hook of the chromatin architectural transcription factor high mobility group A1a is arginine-methylated by protein arginine methyltransferase 6. J Biol Chem 281: 3764-3772.
12. Michaud-Levesque J, Richard S, (2009) Thrombospondin-1 is a transcriptional repression target of PRMT6. J Biol Chem 284: 21338-21346.
13. Harrison MJ, Tang YH, Dowhan DH, (2010) Protein arginine methyltransferase 6 regulates multiple aspects of gene expression. Nucleic Acids Res 38: 2201-2216.
14. Xie B, Invernizzi CF, Richard S, Wainberg MA, (2007) Arginine methylation of the human immunodeficiency virus type 1 Tat protein by PRMT6 negatively affects Tat Interactions with both cyclin T1 and the Tat transactivation region. J Virol 81: 4226-4234.
15. Sivakumaran H, van der Horst A, Fulcher AJ, Apolloni A, Lin MH, et al. (2009) Arginine methylation increases the stability of human immunodeficiency virus type 1 Tat. J Virol 83: 11694-11703.
16. Invernizzi CF, Xie B, Richard S, Wainberg MA, (2006) PRMT6 diminishes HIV-1 Rev binding to and export of viral RNA. Retrovirology 3: 93.
17. Boulanger MC, Liang C, Russell RS, Lin R, Bedford MT, et al. (2005) Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression. J Virol 79: 124-131.
18. El-Andaloussi N, Valovka T, Toueille M, Steinacher R, Focke F, et al. (2006) Arginine methylation regulates DNA polymerase beta. Mol Cell 22: 51-62.
19. Phalke S, Mzoughi S, Bezzi M, Jennifer N, Mok WC, et al. (2012) p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6. Nucleic Acids Res. [Epub ahead of print].
20. Kleinschmidt MA, de Graaf P, van Teeffelen HA, Timmers HT, (2012) Cell Cycle Regulation by the PRMT6 Arginine Methyltransferase through Repression of Cyclin-Dependent Kinase Inhibitors. PLoS One 7: e41446.
21. Stein C, Riedl S, Ruthnick D, Notzold RR, Bauer UM (2012) The arginine methyltransferase PRMT6 regulates cell proliferation and senescence through transcriptional repression of tumor suppressor genes. Nucleic Acids Res. [Epub ahead of print].
22. Neault M, Mallette FA, Vogel G, Michaud-Levesque J, Richard S (2012) Ablation of PRMT6 reveals a role as a negative transcriptional regulator of the p53 tumor suppressor. Nucleic Acids Res [Epub ahead of print].
23. Sgarra R, Tessari MA, Di Bernardo J, Rustighi A, Zago P, et al. (2005) Discovering high mobility group A molecular partners in tumour cells. Proteomics 5: 1494-1506.
24. Tang J, Gary JD, Clarke S, Herschman HR, (1998) PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity, and regulation. J Biol Chem 273: 16935-16945.
25. Malini E, Maurizio E, Bembich S, Sgarra R, Edomi P, et al. (2011) HMGA Interactome: new insights from phage display technology. Biochemistry 50: 3462-3468.
26. Passos DO, Quaresma AJ, Kobarg J, (2006) The methylation of the C-terminal region of hnRNPQ (NSAP1) is important for its nuclear localization. Biochem Biophys Res Commun 346: 517-525.
27. Iwasaki H, (2008) Involvement of PRMT1 in hnRNPQ activation and internalization of insulin receptor. Biochem Biophys Res Commun 372: 314-319.
28. Brahms H, Meheus L, de Brabandere V, Fischer U, Luhrmann R, (2001) Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B′ and the Sm-like protein LSm4, and their interaction with the SMN protein. RNA 7: 1531-1542.
29. Zhang X, Krutchinsky A, Fukuda A, Chen W, Yamamura S, et al. (2005) MED1/TRAP220 exists predominantly in a TRAP/Mediator subpopulation enriched in RNA polymerase II and is required for ER-mediated transcription. Mol Cell 19: 89-100.
30. Angel A, Song J, Dean C, Howard M, (2011) A Polycomb-based switch underlying quantitative epigenetic memory. Nature 476: 105-108.
31. Goulet I, Gauvin G, Boisvenue S, Cote J, (2007) Alternative splicing yields protein arginine methyltransferase 1 isoforms with distinct activity, substrate specificity, and subcellular localization. J Biol Chem 282: 33009-21.
32. Sayegh J, Webb K, Cheng D, Bedford MT, Clarke SG, (2007) Regulation of protein arginine methyltransferase 8 (PRMT8) activity by its N-terminal domain. J Biol Chem 282: 36444-53.
33. Osborne TC, Obianyo O, Zhang X, Cheng X, Thompson PR, (2007) Protein arginine methyltransferase 1: positively charged residues in substrate peptides distal to the site of methylation are important for substrate binding and catalysis. Biochemistry 46: 13370-81.
34. Lee DY, Ianculescu I, Purcell D, Zhang X, Cheng X, et al. (2007) Surface-scanning mutational analysis of protein arginine methyltransferase 1: roles of specific amino acids in methyltransferase substrate specificity, oligomerization, and coactivator function. Mol Endocrinol 21: 1381-93.
35. Antonysamy S, Bonday Z, Campbell RM, Doyle B, Druzina Z, et al. (2012) Crystal structure of the human PRMT5:MEP50 complex. Proc Natl Acad Sci U S A 109: 17960-5.
36. Zhang X, Zhou L, Cheng X, (2000) Crystal structure of the conserved core of protein arginine methyltransferase PRMT3. EMBO J 19: 3509-19.
37. Zhang X, Cheng X, (2003) Structure of the Predominant Protein Arginine Methyltransferase PRMT1 and Analysis of Its Binding to Substrate Peptides. Structure 11: 509-520.
38. Sgarra R, Zammitti S, Lo Sardo A, Maurizio E, Arnoldo L, et al. (2010) HMGA molecular network: From transcriptional regulation to chromatin remodeling. Biochim Biophys Acta 1799: 37-47.
39. Jung H, Seong HA, Ha H, (2008) Critical role of cysteine residue 81 of macrophage migration inhibitory factor (MIF) in MIF-induced inhibition of p53 activity. J Biol Chem 283: 20383-96.
40. Jung H, Seong HA, Ha H, (2008) Direct interaction between NM23-H1 and macrophage migration inhibitory factor (MIF) is critical for alleviation of MIF-mediated suppression of p53 activity. J Biol Chem 283: 32669-79.
41. Frasca F, Rustighi A, Malaguarnera R, Altamura S, Vigneri P, et al. (2006) HMGA1 inhibits the function of p53 family members in thyroid cancer cells. Cancer Res 66: 2980-9.
42. Obianyo O, Thompson PR, (2012) Kinetic mechanism of protein arginine methyltransferase 6 (PRMT6). J Biol Chem 287: 6062-71.